UniProt ID | IL2RG_HUMAN | |
---|---|---|
UniProt AC | P31785 | |
Protein Name | Cytokine receptor common subunit gamma | |
Gene Name | IL2RG | |
Organism | Homo sapiens (Human). | |
Sequence Length | 369 | |
Subcellular Localization |
Membrane Single-pass type I membrane protein. |
|
Protein Description | Common subunit for the receptors for a variety of interleukins.. | |
Protein Sequence | MLKPSLPFTSLLFLQLPLLGVGLNTTILTPNGNEDTTADFFLTTMPTDSLSVSTLPLPEVQCFVFNVEYMNCTWNSSSEPQPTNLTLHYWYKNSDNDKVQKCSHYLFSEEITSGCQLQKKEIHLYQTFVVQLQDPREPRRQATQMLKLQNLVIPWAPENLTLHKLSESQLELNWNNRFLNHCLEHLVQYRTDWDHSWTEQSVDYRHKFSLPSVDGQKRYTFRVRSRFNPLCGSAQHWSEWSHPIHWGSNTSKENPFLFALEAVVISVGSMGLIISLLCVYFWLERTMPRIPTLKNLEDLVTEYHGNFSAWSGVSKGLAESLQPDYSERLCLVSEIPPKGGALGEGPGASPCNQHSPYWAPPCYTLKPET | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
24 | N-linked_Glycosylation | PLLGVGLNTTILTPN HHHCCEECCEEECCC | 29.28 | UniProtKB CARBOHYD | |
71 | N-linked_Glycosylation | VFNVEYMNCTWNSSS EEEEEEEECEECCCC | 21.11 | 16293754 | |
75 | N-linked_Glycosylation | EYMNCTWNSSSEPQP EEEECEECCCCCCCC | 17.54 | UniProtKB CARBOHYD | |
84 | N-linked_Glycosylation | SSEPQPTNLTLHYWY CCCCCCCEEEEEEEE | 37.40 | 16293754 | |
98 | Ubiquitination | YKNSDNDKVQKCSHY EECCCCHHHEEEHHH | 53.47 | - | |
101 | Ubiquitination | SDNDKVQKCSHYLFS CCCHHHEEEHHHHHC | 40.46 | 29967540 | |
119 | Ubiquitination | TSGCQLQKKEIHLYQ CCCCCCCCCEEEEEE | 62.05 | 29967540 | |
120 | Ubiquitination | SGCQLQKKEIHLYQT CCCCCCCCEEEEEEE | 49.27 | - | |
127 | O-linked_Glycosylation | KEIHLYQTFVVQLQD CEEEEEEEEEEECCC | 12.58 | OGP | |
147 | Ubiquitination | RQATQMLKLQNLVIP HHHHHHHHHHCCCCC | 42.56 | - | |
159 | N-linked_Glycosylation | VIPWAPENLTLHKLS CCCCCCCCCEEEECC | 36.95 | 16293754 | |
164 | Ubiquitination | PENLTLHKLSESQLE CCCCEEEECCHHHHH | 57.74 | - | |
198 | O-linked_Glycosylation | TDWDHSWTEQSVDYR CCCCCCCCCHHCCEE | 27.45 | OGP | |
204 | Phosphorylation | WTEQSVDYRHKFSLP CCCHHCCEEECCCCC | 16.68 | 26267517 | |
207 | Ubiquitination | QSVDYRHKFSLPSVD HHCCEEECCCCCCCC | 27.87 | 22505724 | |
217 | Ubiquitination | LPSVDGQKRYTFRVR CCCCCCCCEEEEEEE | 53.56 | - | |
249 | N-linked_Glycosylation | HPIHWGSNTSKENPF CCCCCCCCCCCCCCC | 44.42 | UniProtKB CARBOHYD | |
292 | Phosphorylation | RTMPRIPTLKNLEDL HHCCCCCCCCCHHHH | 48.25 | 9049783 | |
294 | Ubiquitination | MPRIPTLKNLEDLVT CCCCCCCCCHHHHHH | 63.06 | 22817900 | |
301 | Phosphorylation | KNLEDLVTEYHGNFS CCHHHHHHHHCCCHH | 37.82 | - | |
303 | Phosphorylation | LEDLVTEYHGNFSAW HHHHHHHHCCCHHHH | 12.98 | 19901323 | |
308 | Phosphorylation | TEYHGNFSAWSGVSK HHHCCCHHHHCCCCH | 32.59 | - | |
315 | Ubiquitination | SAWSGVSKGLAESLQ HHHCCCCHHHHHHHC | 56.38 | 22817900 | |
320 | Phosphorylation | VSKGLAESLQPDYSE CCHHHHHHHCCCCCC | 27.05 | 23401153 | |
325 | Phosphorylation | AESLQPDYSERLCLV HHHHCCCCCCCEEEE | 21.08 | 28796482 | |
326 | Phosphorylation | ESLQPDYSERLCLVS HHHCCCCCCCEEEEE | 24.50 | 23401153 | |
349 | Phosphorylation | LGEGPGASPCNQHSP CCCCCCCCCCCCCCC | 35.58 | 27080861 | |
355 | Phosphorylation | ASPCNQHSPYWAPPC CCCCCCCCCCCCCCC | 15.21 | 27080861 | |
357 | Phosphorylation | PCNQHSPYWAPPCYT CCCCCCCCCCCCCCC | 19.74 | 27259358 | |
363 | Phosphorylation | PYWAPPCYTLKPET- CCCCCCCCCCCCCC- | 22.38 | 19901323 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of IL2RG_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IL2RG_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CPNS1_HUMAN | CAPNS1 | physical | 9326644 | |
IL4RA_HUMAN | IL4R | physical | 12242343 | |
JAK1_HUMAN | JAK1 | physical | 8041779 | |
JAK2_HUMAN | JAK2 | physical | 8041779 | |
I13R1_HUMAN | IL13RA1 | physical | 12207328 | |
STK4_HUMAN | STK4 | physical | 21988832 | |
KR103_HUMAN | KRTAP10-3 | physical | 25416956 | |
NT2NL_HUMAN | NOTCH2NL | physical | 25416956 | |
NFIP2_HUMAN | NDFIP2 | physical | 26186194 | |
FLVC1_HUMAN | FLVCR1 | physical | 26186194 | |
PTPRD_HUMAN | PTPRD | physical | 26186194 | |
REEP6_HUMAN | REEP6 | physical | 26186194 | |
IL2_HUMAN | IL2 | physical | 11418623 | |
IL21_HUMAN | IL21 | physical | 11418623 | |
REEP6_HUMAN | REEP6 | physical | 28514442 | |
CD320_HUMAN | CD320 | physical | 28514442 | |
PTPRD_HUMAN | PTPRD | physical | 28514442 | |
FLVC1_HUMAN | FLVCR1 | physical | 28514442 | |
JAK3_HUMAN | JAK3 | physical | 27742835 | |
GRB10_HUMAN | GRB10 | physical | 27742835 | |
NED4L_HUMAN | NEDD4L | physical | 27742835 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00080 | Systemic lupus erythematosus | |||||
H00091 | T-B+Severe combined immunodeficiencies (SCIDs), including the following eight diseases: X-linked SCI | |||||
H00093 | Combined immunodeficiencies (CIDs), including the following nine diseases: X-linked hyper IgM syndro | |||||
OMIM Disease | ||||||
300400 | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) | |||||
312863 | X-linked combined immunodeficiency (XCID) | |||||
Kegg Drug | ||||||
D00748 | Aldesleukin (USAN/INN); Interleukin-2; Proleukin (TN) | |||||
D02743 | Celmoleukin (genetical recombination) (JP16); Celmoleukin (INN); Celeuk (TN) | |||||
D02749 | Teceleukin (genetical recombination) (JP16); Teceleukin (USAN); Imunace (TN) | |||||
D03682 | Denileukin diftitox (USAN/INN); Ontak (TN) | |||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Crystal structure of the IL-2 signaling complex: paradigm for aheterotrimeric cytokine receptor."; Stauber D.J., Debler E.W., Horton P.A., Smith K.A., Wilson I.A.; Proc. Natl. Acad. Sci. U.S.A. 103:2788-2793(2006). Cited for: X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 23-255 IN COMPLEX WITH IL2;IL2RA AND IL2RB, DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-71; ASN-84AND ASN-159. | |
"Structure of the quaternary complex of interleukin-2 with its alpha,beta, and gammac receptors."; Wang X., Rickert M., Garcia K.C.; Science 310:1159-1163(2005). Cited for: X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 56-254 IN COMPLEX WITH IL2;IL2RA AND IL2RB, DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-71; ASN-84AND ASN-159. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-292, AND MASSSPECTROMETRY. |